Q5111 Pegfilgrastim-cbqv - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Pegfilgrastim-cbqv

Brand Name:

Udenyca

Strength:

0.5mg

HCPCS:

Q5111

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Immunostimulant

Minor Drug Class:

Granulocyte Colony-Stimulating Factor

Oral (Y/N):

No

FDA Approval Year:

2019

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2019

CMS Discontinuation Date:

Status:

In Use